118 related articles for article (PubMed ID: 4020325)
1. 3H-labelled RU 38486: characterization of binding sites in human uterine cytosol.
Heubner A; Pollow K; Manz B; Grill HJ; Belovsky O
J Clin Chem Clin Biochem; 1985 May; 23(5):265-76. PubMed ID: 4020325
[TBL] [Abstract][Full Text] [Related]
2. 3H-ZK 98,734, a new 11 beta-aryl substituted antigestagen: binding characteristics to receptor and serum proteins.
Pollow K; Juchem M; Grill HJ; Manz B; Beier S; Henderson D; Schmidt-Gollwitzer K; Elger W
Contraception; 1989 Aug; 40(2):213-32. PubMed ID: 2758842
[TBL] [Abstract][Full Text] [Related]
3. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
[TBL] [Abstract][Full Text] [Related]
4. [Binding characteristics of RU 486 with glucocorticoid and progestin receptors].
Fukuoka H; Jimbo T
Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):698-706. PubMed ID: 3224726
[TBL] [Abstract][Full Text] [Related]
5. Evidence for separate binding sites for progesterone and RU486 in the chick oviduct.
Moudgil VK; Lombardo G; Hurd C; Eliezer N; Agarwal MK
Biochim Biophys Acta; 1986 Nov; 889(2):192-9. PubMed ID: 3778947
[TBL] [Abstract][Full Text] [Related]
6. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
Hurd C; Moudgil VK
Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
[TBL] [Abstract][Full Text] [Related]
7. Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.
Moudgil VK; Hurd C
Biochemistry; 1987 Aug; 26(16):4993-5001. PubMed ID: 3663641
[TBL] [Abstract][Full Text] [Related]
8. Immunologically distinct binding molecules for progesterone and RU38486 in the chick oviduct cytosol.
Eliezer N; Hurd CB; Moudgil VK
Biochim Biophys Acta; 1987 Jun; 929(1):34-9. PubMed ID: 3593772
[TBL] [Abstract][Full Text] [Related]
9. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486.
Schmidt TJ
J Steroid Biochem; 1986 Apr; 24(4):853-63. PubMed ID: 2871233
[TBL] [Abstract][Full Text] [Related]
10. Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).
Miller MM; Hurd C; Moudgil VK
J Steroid Biochem; 1988 Nov; 31(5):777-83. PubMed ID: 3199817
[TBL] [Abstract][Full Text] [Related]
11. The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.
Renoir JM; Radanyi C; Baulieu EE
Steroids; 1989; 53(1-2):1-20. PubMed ID: 2772964
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to human fertility control: contragestion by the anti-progesterone RU 486.
Baulieu EE
Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):125-9. PubMed ID: 3402651
[TBL] [Abstract][Full Text] [Related]
13. Differences in the association of the progesterone receptor ligated by antiprogestin RU38486 or progestin ORG 2058 to chromatin components.
Geier A; Bella R; Beery R; Haimsohn M; Lunenfeld B
Biochim Biophys Acta; 1987 Oct; 931(1):78-86. PubMed ID: 3651513
[TBL] [Abstract][Full Text] [Related]
14. Transplacental passage of mifepristone.
Frydman R; Taylor S; Ulmann A
Lancet; 1985 Nov; 2(8466):1252. PubMed ID: 2866332
[No Abstract] [Full Text] [Related]
15. Plasma concentrations and receptor binding of RU 486 and its metabolites in humans.
Heikinheimo O; Kontula K; Croxatto H; Spitz I; Luukkainen T; Lähteenmäki P
J Steroid Biochem; 1987 Feb; 26(2):279-84. PubMed ID: 3560943
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of female sexual behavior with intracerebral implants of antiprogestin RU 38486: correlation with binding to neural progestin receptors.
Etgen AM; Barfield RJ
Endocrinology; 1986 Oct; 119(4):1610-7. PubMed ID: 3757904
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
Schmidt TJ
Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
[TBL] [Abstract][Full Text] [Related]
18. Effect of the antiprogestin RU-486 on progesterone inhibition of occupied nuclear estrogen receptor in the uterus.
Okulicz WC
J Steroid Biochem; 1987 Aug; 28(2):117-22. PubMed ID: 3626549
[TBL] [Abstract][Full Text] [Related]
19. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
Moudgil VK; Anter MJ; Hurd C
J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
[TBL] [Abstract][Full Text] [Related]
20. Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.
Mizutani T; Bhakta A; Kloosterboer HJ; Moudgil VK
J Steroid Biochem Mol Biol; 1992 Aug; 42(7):695-704. PubMed ID: 1504008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
